Clotting prevention is one of the key problems in renal replacement therapy. In this review traditional heparini- zation and its complications, low molecular weight heparins, which are wide used in programme haemodialysis, treatment without anticoagulants, regional citrate anticoagulantion, as well as new alternative anticoagulants are considered.
